Dempfle C-E
I. Medizinische Klinik, Universitätsklinikum Mannheim.
Anaesthesist. 2005 Feb;54(2):167-75; quiz 176-7. doi: 10.1007/s00101-005-0802-9.
The main diagnostic tool for the preoperative identification of patients with an increased risk of bleeding or thrombosis is the patient history. Laboratory diagnostics should only be performed if a bleeding diathesis is suspected from patient history or clinical symptoms of bleeding, or if an adequate patient history cannot be performed. Measurement of prothrombin time, aPTT, or bleeding time as a general preoperative screening procedure is neither cost-effective nor efficient for the identification of patients with increased bleeding risk. Normal values of prothrombin time and aPTT do not exclude the most prevalent bleeding disorder, von Willebrand's disease. A normal platelet count does not exclude a severe platelet function defect. Selection of specific laboratory assays is performed on the basis of the individual patient history and clinical picture; laboratory 'profiles' can be defined for some specific clinical conditions. In some cases, patients should be referred to a specialized coagulation clinic for further diagnostics and treatment planning. Preoperative laboratory diagnostics for thrombophilia are not necessary in most cases. The decision for intensified antithrombotic measures is made according to patient history and the postoperative clinical course.
术前识别出血或血栓形成风险增加患者的主要诊断工具是患者病史。仅当根据患者病史或出血临床症状怀疑有出血素质,或无法获取充分的患者病史时,才应进行实验室诊断。将凝血酶原时间、活化部分凝血活酶时间或出血时间作为常规术前筛查程序,对于识别出血风险增加的患者既不具有成本效益,也效率不高。凝血酶原时间和活化部分凝血活酶时间的正常数值并不能排除最常见的出血性疾病——血管性血友病。血小板计数正常并不能排除严重的血小板功能缺陷。应根据个体患者病史和临床表现选择特定的实验室检测;对于某些特定临床情况,可以定义实验室“概况”。在某些情况下,应将患者转诊至专业凝血诊所进行进一步诊断和治疗规划。大多数情况下,术前无需进行血栓形成倾向的实验室诊断。强化抗血栓措施的决策应根据患者病史和术后临床病程做出。